CytomX Therapeutics, Inc.

NasdaqGS:CTMX Stock Report

Mkt Cap: US$166.5m

CytomX Therapeutics Company Information

CytomX Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: CytomX Therapeutics, Inc.
  • Ticker: CTMX
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$166.533m
  • Shares outstanding: 66.08m
  • Website:

Number of Employees


  • CytomX Therapeutics, Inc.
  • 151 Oyster Point Boulevard
  • Suite 400
  • South San Francisco
  • California
  • 94080
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CTMXNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDOct 2015
6C1DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/23 00:00
End of Day Share Price2023/01/20 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.